Related Experiment Videos
An overview of the cell cycle arrest protein, p21(WAF1)
1Oral Diseases Group, Unit of Oral Surgery and Medicine, Dundee Dental Hospital and School, Park Place, DD1 4HN, UK. kharada@bad.dundee.ac.uk
Abstract:
p21, also known as WAF1, Cip1, Sdi1, Mda 6 and Cap20 is a cell cycle protein that regulates and can arrest the cell cycle in G1 or S phase (either dependent or independent of p53). Its role may be pivotal in many cell processes including differentiation and apoptosis. This brief overview provides a summary of its presently known functions and indicates areas for further research, particularly in relation to oral malignant disease. Greater understanding of its role may lead to therapeutic advances in the management of malignant disease.
Insights
The cell cycle protein p21 (WAF1/Cip1) regulates cell division and may be key in cancer development. Further research into p21
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The p21 protein (also known as WAF1/Cip1) is a key regulator of the cell cycle.
- It plays a role in cell cycle arrest at G1 or S phase, potentially independent of p53.
- p21 is implicated in crucial cellular processes such as differentiation and apoptosis.
Purpose of the Study:
- To provide a comprehensive overview of the known functions of the p21 protein.
- To highlight areas requiring further investigation regarding p21's role.
- To explore the specific relevance of p21 in the context of oral malignant diseases.
Main Methods:
- Literature review of existing studies on p21.
- Analysis of p21's known functions in cell cycle regulation.
- Exploration of p21's involvement in differentiation and apoptosis.
Main Results:
- p21 functions as a cell cycle regulator, capable of arresting the cell cycle.
- Its functions extend to cellular differentiation and apoptosis.
- Evidence suggests a significant role in oral malignant disease.
Conclusions:
- Understanding p21's multifaceted roles is crucial for advancing cancer research.
- Targeting p21 may offer novel therapeutic strategies for managing malignant diseases, particularly oral cancers.
- Further research is warranted to fully elucidate p21's mechanisms and therapeutic potential.